|
1
|
Gottesman MM and Ling V: The molecular
basis of multidrug resistance in cancer: The early years of
P-glycoprotein research. FEBS Lett. 580:998–1009. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Choi CH: ABC transporters as multidrug
resistance mechanisms and the development of chemosensitizers for
their reversal. Cancer Cell Int. 5:302005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Leslie EM, Deeley RG and Cole SP:
Multidrug resistance proteins: Role of P-glycoprotein, MRP1, MRP2,
and BCRP (ABCG2) in tissue defense. Toxicol Appl Pharmacol.
204:216–237. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cole SP: Targeting multidrug resistance
protein 1 (MRP1, ABCC1): Past, present, and future. Annu Rev
Pharmacol Toxicol. 54:95–117. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sharom FJ: ABC multidrug transporters:
Structure, function and role in chemoresistance. Pharmacogenomics.
9:105–127. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chikamori K, Grozav AG, Kozuki T,
Grabowski D, Ganapathi R and Ganapathi MK: DNA topoisomerase II
enzymes as molecular targets for cancer chemotherapy. Curr Cancer
Drug Targets. 10:758–771. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kartal-Yandim M, Adan-Gokbulut A and Baran
Y: Molecular mechanisms of drug resistance and its reversal in
cancer. Crit Rev Biotechnol. 36:716–726. 2016.PubMed/NCBI
|
|
8
|
Ren SX: The potential of Chinese herb on
multidrug resistance. Pharmacy Clinics Chinese Materia Med.
3:57–60. 2012.
|
|
9
|
Liao SL and Wang P: Research progress on
multidrug resistance mechanism of cancer cells and its reversal
agents. Guowai Yiyao Kangshengsu Fence. 1:7–11. 2008.(In
Chinese).
|
|
10
|
Pan GD and Yan L: Advances in gene therapy
of multidrug resistance reversal induced by Mdr1. Huaxi Yixue.
22:205–207. 2007.(In Chinese).
|
|
11
|
Sharom FJ: The P-glycoprotein multidrug
transporter. Essays Biochem. 50:161–178. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cascorbi I: P-glycoprotein: Tissue
distribution, substrates, and functional consequences of genetic
variations. Handb Exp Pharmacol. 261–283. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jones PM and George AM: Mechanism of the
ABC transporter ATPase domains: Catalytic models and the
biochemical and biophysical record. Crit Rev Biochem Mol Biol.
48:39–50. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ward AB, Szewczyk P, Grimard V, Lee CW,
Martinez L, Doshi R, Caya A, Villaluz M, Pardon E, Cregger C, et
al: Structures of P-glycoprotein reveal its conformational
flexibility and an epitope on the nucleotide-binding domain. Proc
Natl Acad Sci USA. 110:13386–13391. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ueda K, Cornwell MM, Gottesman MM, Pastan
I, Roninson IB, Ling V and Riordan JR: The mdr1 gene, responsible
for multidrug-resistance, codes for P-glycoprotein. Biochem Biophys
Res Commun. 141:956–962. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Loo TW and Clarke DM: Recent progress in
understanding the mechanism of P-glycoprotein-mediated drug efflux.
J Membr Biol. 206:173–185. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Crowley E, McDevitt CA and Callaghan R:
Generating inhibitors of P-glycoprotein: Where to, now? Methods Mol
Biol. 596:405–432. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tsuruo T, Iida H, Tsukagoshi S and Sakurai
Y: Overcoming of vincristine resistance in P388 leukemia in vivo
and in vitro through enhanced toxicity of vincristine and
vinblastine by verapamil. Cancer Res. 41:1967–1972. 1981.PubMed/NCBI
|
|
19
|
Tamaki A, Ierano C, Szakacs G, Robey RW
and Bates SE: The controversial role of ABC transporters in
clinical oncology. Essays Biochem. 50:209–232. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Huang SC, Xu J and Cai SH: Research
progress of targeted reverse MDR mediated by P-glycoprotein. Huaxi
Yaoxue Zazhi. 24:551–554. 2009.(In Chinese).
|
|
21
|
Shen XL, Hu YJ, Yu ZL and Fong WF:
Research progress on reversal of multidrug resistance of
P-glycoprotein mediated by Chinese Herbs. Chinese J Natural Med.
7:465–475. 2009. View Article : Google Scholar
|
|
22
|
Pusztai L, Wagner P, Ibrahim N, Rivera E,
Theriault R, Booser D, Symmans FW, Wong F, Blumenschein G, Fleming
DR, et al: Phase II study of tariquidar, a selective P-glycoprotein
inhibitor, in patients with chemotherapy resistant, advanced breast
carcinoma. Cancer. 104:682–691. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li P and Chen S: Study of the ginsenoside
Rh2 reversal MCF-7/ADM multidrug resistance. Guide Chin Med.
11:8–10. 2013.(In Chinese).
|
|
24
|
Piao L, Cai Y, Zhang M, Jiang J, Jin Z and
Xu Z: Effects of gensenoside Rh2 combined with PI3K/AKT pathway
inhibitor LY294002 on invasion and migration of breast cancer
cells. China Pharmacy. 24:4050–4052. 2013.
|
|
25
|
Xu X, Shi S, Tang Y, Shen H and Qian B:
Therapeutic effects of ginsenoside Rh2 on multi-drug resistant
leukemia cell line K562/VCR. Chin Trad Herbal Drugs. 41:1131–1135.
2010.(In Chinese).
|
|
26
|
Zhang B, Liu ZY, Li YY, Luo Y, Liu ML,
Dong HY, Wang YX, Liu Y, Zhao PT, Jin FG and Li ZC:
Antiinflammatory effects of matrine in LPS-induced acute lung
injury in mice. Eur J Pharm Sci. 44:573–579. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhaowu Z, Xiaoli W, Yangde Z and Nianfeng
L: Preparation of matrine ethosome, its percutaneous permeation in
vitro and anti-inflammatory activity in vivo in rats. J Liposome
Res. 19:155–162. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang Y, Xiu J, Zhang X, Zhang L, Yan K,
Qin C and Liu J: Antiviral effect of matrine against human
enterovirus 71. Molecules. 17:10370–10376. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li LQ, Li XL, Wang L, Du WJ, Guo R, Liang
HH, Liu X, Liang DS, Lu YJ, Shan HL and Jiang HC: Matrine inhibits
breast cancer growth via miR-21/PTEN/Akt pathway in MCF-7 cells.
Cell Physiol Biochem. 30:631–641. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jin H, Sun Y, Wang S and Cheng X: Matrine
activates PTEN to induce growth inhibition and apoptosis in
V600EBRAF harboring melanoma cells. Int J Mol Sci. 14:16040–16057.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang S, Zhang Y, Zhuang Y, Wang J, Ye J,
Zhang S, Wu J, Yu K and Han Y: Matrine induces apoptosis in human
acute myeloid leukemia cells via the mitochondrial pathway and Akt
inactivation. PLoS One. 7:e468532012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yan F, Liu Y and Wang W: Matrine inhibited
the growth of rat osteosarcoma UMR-108 cells by inducing apoptosis
in a mitochondrial-caspase-dependent pathway. Tumour Biol.
34:2135–2140. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gui L, Li J, Chen B, Gao F, Wang J and Cai
X: Effect of COX-2 inhibitor celecoxib, matrine and combination on
multidrug resistance of K562/AO2 cell line. J Southeast Univ (Med
Sci Edi). 31:174–178. 2012.
|
|
34
|
Wei C, Shen Y, Zhang Z, Wang J and Zhou B:
Matrine reverses multidrug resistance in breast cancer
drug-resistant cell line MCF-7/ADR through inhibiting PI3K/AKT
signal pathway. J Third Mil Med Univ. 36:2254–2258. 2014.
|
|
35
|
Zhan T: Matrine induces apoptosis of
multidrug resistant CRBH-7919/mdr1 cells. Jilin Univ 1–84. 2012.(In
Chinese).
|
|
36
|
Wang J, Wang G and Liu M: Effects of
quercetin on reversion of temozolomide resistance in U87/TR cell
line. Yiyao Dao Bao. 32:710–714. 2013.(In Chinese).
|
|
37
|
Wang H, Zhang H, Tao L, et al:
Quercetin-induced strengthening efficiency to tamoxifen in
tamoxifen-resistant breast cancer cells. Chin J Modern Med.
24:39–44. 2014.(In Chinese).
|
|
38
|
Wang Y, Liu Z, Zhang Q, Gao X, Zhang L and
Liu H: Effect of quercetin on multidrug resistance reversal of lung
adenocarcinoma cell line A549/DDP. J Binzhou Med Univ. 26:86–89.
2013.
|
|
39
|
Wei Y, Zhang H and Liang G: The reverse
effect of quercetin on multidrug resistance of human hepatocellular
carcinoma. Tianjin Med J. 40:1022–1025. 2013.
|
|
40
|
He HL, Ji LJ, Li QZ, Zhang R, Huang JM and
Li G: Effect of quercetin on doxorubicin-induced expression of MDR1
gene in HL-60 cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 23:70–76.
2015.(In Chinese). PubMed/NCBI
|
|
41
|
Ma J, Yang J and Shen H: The chemotherapy
sensitivity analysis of the impact of reactive oxygen species on
ovarian cancer cells COC1 and COC1/DDP. Biol Med Res Intl.
30:535–539. 2014.(In Chinese).
|
|
42
|
Li J, Liu P, Mao H, Wanga A and Zhang X:
Emodin sensitizes paclitaxel-resistant human ovarian cancer cells
to paclitaxel-induced apoptosis in vitro. Oncol Rep. 21:1605–1610.
2009.PubMed/NCBI
|
|
43
|
Yu X, Wang S, Cao Y, Mo C, Li X and Li M:
Effects of tetramethylpyrazine on P-glycoprotein in human drug
resistant hepatocellular carcinoma cells BEL-7402/ADM. J Guangdong
Pharmaceut Coll. 26:635–639. 2010.(In Chinese).
|
|
44
|
Zhang Y, Liu X, Zuo T, Liu Y and Zhang JH:
Tetramethylpyrazine reverses multidrug resistance in breast cancer
cells through regulating the expression and function of
P-glycoprotein. Med Oncol. 29:534–538. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yang L, Zhao T, Bai Q and Dong H: Reversal
effect and mechanism induced by baicalin on leukemia cell line.
Shaxi Yixue Zazhi. 7:775–779. 2012.(In Chinese).
|
|
46
|
Huang M, Jin J, Sun H and Liu GT: Reversal
of P-glycoprotein-mediated multidrug resistance of cancer cells by
five schizandrins isolated from the Chinese herb Fructus
Schizandrae. Cancer Chemother Pharmacol. 62:1015–1026. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wang M, Liu H, Yan M and Liu Z: Reversal
effect of SchB on bladder tumor multidrug resistance. Natl Med
Front Chin. 5:28–29. 2010.(In Chinese).
|
|
48
|
Li QP and Gai YN: Schisandrin B reverses
multidrug resistance due to MDR1-mediatied human osteosarcoma cell
line U-2 OS/ADR. Anhui Med Pharmaceut J. 18:1642–1645. 2014.
|
|
49
|
Xu Q, Jin X, Guo R, Zhang X and Liu G:
Schisandrin B reverses multidrug resistance of human colon cancer
cells. Food Nutr Chin. 17:64–66. 2011.(In Chinese).
|
|
50
|
Qiangrong P, Wang T, Lu Q and Hu X:
Schisandrin B-a novel inhibitor of P-glycoprotein. Biochem Biophys
Res Commun. 335:406–411. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
He JB, Liao HZ, Zhang YQ, et al: Reversal
effect of ginsenoside Rg3 on multidrug resistance of lung
adenocarcinoma in mice. J Practical Oncol. 4:373–377. 2006.(In
Chinese).
|
|
52
|
Li G, Wang M, Sun F, Wang X, Li X and Yin
G: Reversal effect of multidrug resistance associated gene
overexpression mediated induced by matrine on S180-tumor-bearing
mice. J Chin Med Mater. 29:40–42. 2006.(In Chinese).
|
|
53
|
Han L, Wang Y, Guo X, Zhou Y, Zhang J,
Wang N, Jiang J, Ma F and Wang Q: Downregulation of MDR1 gene by
cepharanthine hydrochloride is related to the activation of
c-Jun/JNK in K562/ADR cells. Biomed Res Int. 2014:1643912014.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Han L: The multidrug resistance reversal
effect of cepharanthine hydrochloride and its mechanism. Zhengzhou:
Zhengzhou Univ 1–119. 2013.(In Chinese).
|
|
55
|
Lu W, Fu Z, Qin Y, Li L and Yang C:
Curcumin reverses multidrug resistance in HCT-8/VCR nude mice
xenograft. Di San Jun Yi Da Xue Xue Bao Bian Ji Bu. 33:376–380.
2011.(In Chinese).
|
|
56
|
Xu DH: Overcome multidrug resistance by
doxorubicin nanocarriers. Zhejiang Univ 1–153. 2008.(In
Chinese).
|
|
57
|
Wang S, Yu S, Shi W, Ge L, Yu X, Fan J and
Zhang J: Curcumin inhibits the migration and invasion of mouse
hepatoma Hca-F cells through down-regulating caveolin-1 expression
and epidermal growth factor receptor signaling. IUBMB Life.
63:775–782. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Liu TY, Tan ZJ, Jiang L, Gu JF, Wu XS, Cao
Y, Li ML, Wu KJ and Liu YB: Curcumin induces apoptosis in
gallbladder carcinoma cell line GBC-SD cells. Cancer Cell Int.
13:642013. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Xia Q, Wang ZY, Li HQ, Diao YT, Li XL, Cui
J, Chen XL and Li H: Reversion of P-glycoprotein mediated multidrug
resistance in human leukemic cell line by diallyl trisulfide. Evid
Based Complement Alternat Med. 2012:7198052012. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Zhao B: Molecular mechanisms of multi-drug
resistance reversal via inhibition of P-glycoprotein function and
expression by Grape seed procyanidin. Guangdong: Southern Medical
Univ 1–210. 2014.(In Chinese).
|
|
61
|
Yuan F, Bai G, Miao YJ, Chen Y, Chen JW
and Li X: Effects of annonaceous acetogenins against multidrug
resistant human breast cancer cell line MCF-7/ADR in vitro. Chin
Trad Herbal Drugs. 45:2815–2819. 2014.
|
|
62
|
Sun YF and Wink M: Tetrandrine and
fangchinoline, bisbenzylisoquinoline alkaloids from Stephania
tetrandracan reverse multidrug resistance by inhibiting
P-glycoprotein activity in multidrug resistant human cancer cells.
Phytomedicine. 21:1110–1119. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Susa M, Choy E, Yang C, Schwab J, Mankin
H, Hornicek F and Duan Z: Multidrug resistance reversal agent,
NSC77037, identified with a cell-based screening assay. J Biomol
Screen. 15:287–296. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Wei N, Sun H, Wang F and Liu G: H1, a
novel derivative of tetrandrine reverse P-glycoprotein-mediated
multidrug resistance by inhibiting transport function and
expression of P-glycoprotein. Cancer Chemother Pharmacol.
67:1017–1025. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Cai Y and Cai T: Reversal effect of
psoralen on leukemia cell K562/ADR multidrug resistance. Zhongguo
Yaolixue Tongbao. 1164–1166. 2003.(In Chinese).
|
|
66
|
Qing Q, Xiao X and Xie Z: Effect of
neferine combined with mdr-1shRNA on the expression of mdr-1/P-gp
in K562/A02 cell line. Zhong Nan Da Xue Xue Bao Yi Xue Ban.
35:445–450. 2010.(In Chinese). PubMed/NCBI
|
|
67
|
Huang C, Cao P, Xie Z and Zhu H: Effect of
different heating methods combined with neferine on the expressions
of γH2AX and mdr-1/P-gp in MCF-7/Adr breast cancer cells. Zhong Nan
Da Xue Xue Bao Yi Xue Ban. 36:317–322. 2011.(In Chinese).
PubMed/NCBI
|
|
68
|
Li Z, An C, Hu K, Zhou K, Duan H and Tang
M: Multidrug resistance reversal activity of total alkaloid from
Fritillaria thunbergii on cisplatin-resistant human lung
adenocarcinoma A549/DDP cells. Chin J Pharmacol Toxicol.
27:315–320. 2013.
|
|
69
|
Xu HB, Li L and Liu GQ: Reversal of
P-glycoprotein-mediated multidrug resistance by guggulsterone in
doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
Pharmazie. 64:660–665. 2009.PubMed/NCBI
|
|
70
|
Xu HB, Xu LZ, Li L, Fu J and Mao XP:
Reversion of P-glycoprotein-mediated multidrug resistance by
guggulsterone in multidrug-resistant human cancer cell lines. Eur J
Pharmacol. 694:39–44. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Yu H, Cui L and Pan Y: Reversal of drug
resistance in multidrug-resistant MCF-7/ADR cells of breast cancer
by artemisinin. Acta Med Univ Sci Technol Huazhong. 40:91–94.
2011.(In Chinese).
|
|
72
|
Liao K, Niu F, Hao H and Wang G: Advances
on structure-activity relationship of NQO1-target antitumor
quinones. Chin J Nat Med. 10:170–176. 2012. View Article : Google Scholar
|
|
73
|
Liao SG, Wang Z, Li J, Liu Y, Li YT, Zhang
LJ, Long QD and Wang YL: Cytotoxic sesquiterpene lactones from
Vernonia bockiana. Chin J Nat Med. 10:230–233. 2012. View Article : Google Scholar
|
